Feedback / Questions
CB-010 - Caribou Biosci
https://www.globenewswire.com/news-release/2024/06/02/2891868/0/en/Caribou-Biosciences-Presents-Encouraging-Clinical-Data-from-CB-010-ANTLER-Phase-1-Trial-in-Second-line-LBCL-Patients-at-the-2024-American-Society-of-Clinical-Oncology-ASCO-Annual-M.html
Jun 2, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next